matrine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bongarzone, S; Gee, AD; Luzi, F; Savickas, V | 1 |
| Bharate, SB; Joshi, P; Vishwakarma, RA | 1 |
| Jiang, J; Muhammad, Y; Rashid, HU; Wang, L; Xu, Y | 1 |
3 review(s) available for matrine and Neoplasms
| Article | Year |
|---|---|
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Drug Discovery; Glycation End Products, Advanced; Humans; Molecular Targeted Therapy; Neoplasms; Neurodegenerative Diseases; Protein Domains; Protein Isoforms; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Small Molecule Libraries | 2017 |
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2017 |
Research advances on anticancer activities of matrine and its derivatives: An updated overview.
Topics: Alkaloids; Antineoplastic Agents; Biomedical Research; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Matrines; Molecular Conformation; Neoplasms; Quinolizines; Sophora; Structure-Activity Relationship | 2019 |